Table 2.
Top 50 genes positively correlated with ZEB1 in 38 NSCLC cell lines.
| Spearman R values1 | ||||||||
|---|---|---|---|---|---|---|---|---|
| RANK | SYMBOL | ZEB1 | ZEB2 | SNAIL | SLUG | TWIST1 | TWIST2 | NAME |
| 1 | VIM | 0.76 | 0.62 | 0.11 | −0.06 | 0.15 | 0.00 | vimentin |
| 2 | MSRB3 | 0.75 | 0.67 | 0.13 | 0.01 | 0.19 | 0.10 | methionine sulfoxide reductase B3 |
| 3 | TXNDC15 | 0.74 | 0.40 | −0.05 | −0.33 | 0.16 | 0.16 | thioredoxin domain containing 15 |
| 4 | SACS | 0.73 | 0.66 | −0.01 | 0.12 | 0.18 | 0.25 | spastic ataxia of Charlevoix-Saguenay (sacsin) |
| 5 | ZEB2 | 0.71 | 1.00 | 0.17 | 0.11 | 0.15 | 0.04 | zinc finger E-box binding homeobox 2 |
| 6 | FGFR1 | 0.70 | 0.49 | 0.13 | −0.11 | 0.40 | 0.23 | fibroblast growth factor receptor 1 |
| 7 | DENND5A | 0.70 | 0.54 | −0.07 | −0.10 | 0.27 | 0.04 | DENN/MADD domain containing 5A |
| 8 | SLC2A14, A3 | 0.69 | 0.58 | 0.25 | −0.28 | −0.02 | 0.07 | solute carrier family 2, member 14 and 3 |
| 9 | LIX1L | 0.69 | 0.57 | 0.11 | −0.23 | 0.12 | 0.22 | Lix1 homolog (mouse)-like |
| 10 | SLC2A3 | 0.69 | 0.61 | 0.26 | −0.29 | −0.04 | 0.04 | solute carrier family 2 member 3 |
| 11 | ST3GAL2 | 0.69 | 0.69 | 0.39 | −0.02 | 0.29 | 0.09 | ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
| 12 | DENND5B | 0.68 | 0.66 | 0.21 | −0.09 | 0.17 | −0.06 | DENN/MADD domain containing 5B |
| 13 | JAM3 | 0.68 | 0.52 | 0.45 | −0.14 | 0.06 | 0.11 | junctional adhesion molecule 3 |
| 14 | SYDE1 | 0.68 | 0.69 | 0.35 | 0.06 | 0.19 | 0.23 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
| 15 | PMP22 | 0.68 | 0.66 | 0.44 | −0.06 | −0.13 | 0.08 | peripheral myelin protein 22 |
| 16 | SLC16A6 | 0.68 | 0.48 | 0.01 | 0.10 | 0.14 | 0.09 | solute carrier family 16, member 6 |
| 17 | MAP1B | 0.68 | 0.51 | 0.10 | −0.08 | 0.22 | 0.06 | microtubule-associated protein 1B |
| 18 | TTC28 | 0.67 | 0.55 | 0.29 | −0.32 | 0.02 | 0.02 | tetratricopeptide repeat domain 28 |
| 19 | COL5A2 | 0.67 | 0.54 | 0.28 | −0.21 | −0.17 | −0.25 | collagen, type V, alpha 2 |
| 20 | NFX1 | 0.65 | 0.55 | 0.15 | −0.10 | −0.07 | 0.07 | nuclear transcription factor, X-box binding 1 |
| 21 | CNRIP1 | 0.65 | 0.75 | 0.27 | 0.26 | 0.30 | 0.11 | cannabinoid receptor interacting protein 1 |
| 22 | RECK | 0.65 | 0.75 | 0.09 | 0.07 | 0.28 | 0.24 | reversion-inducing-cysteine-rich protein with kazal motifs |
| 23 | EMP3 | 0.65 | 0.71 | 0.29 | 0.03 | 0.22 | −0.10 | epithelial membrane protein 3 |
| 24 | BATF3 | 0.65 | 0.59 | 0.30 | −0.21 | −0.07 | 0.02 | basic leucine zipper transcription factor, ATF-like 3 |
| 25 | TMEM158 | 0.65 | 0.41 | 0.11 | 0.18 | 0.38 | 0.21 | transmembrane protein 158 |
| 26 | OSBPL6 | 0.65 | 0.35 | 0.11 | −0.25 | −0.12 | −0.09 | oxysterol binding protein-like 6 |
| 27 | CAP2 | 0.64 | 0.60 | 0.15 | −0.03 | 0.36 | 0.14 | CAP, adenylate cyclase-associated protein, 2 |
| 28 | LEPRE1 | 0.64 | 0.53 | 0.02 | −0.16 | 0.18 | 0.13 | leucine proline-enriched proteoglycan (leprecan) 1 |
| 29 | AZI2 | 0.64 | 0.31 | 0.20 | −0.04 | 0.10 | 0.17 | 5-azacytidine induced 2 |
| 30 | TPK1 | 0.64 | 0.63 | 0.12 | −0.01 | −0.10 | −0.06 | thiamin pyrophosphokinase 1 |
| 31 | SIRT1 | 0.64 | 0.36 | 0.06 | −0.50 | −0.08 | −0.17 | sirtuin 1 |
| 32 | NBPF10, 11 | 0.64 | 0.40 | 0.06 | 0.10 | 0.29 | 0.14 | neuroblastoma breakpoint family, member 10 and 11 |
| 33 | STX2 | 0.64 | 0.60 | 0.19 | 0.03 | 0.24 | −0.06 | syntaxin 2 |
| 34 | DLX1 | 0.64 | 0.56 | 0.11 | 0.01 | 0.39 | 0.14 | distal-less homeobox 1 |
| 35 | SLC47A1 | 0.63 | 0.47 | 0.27 | −0.13 | 0.11 | 0.49 | solute carrier family 47, member 1 |
| 36 | FAM55C | 0.63 | 0.56 | −0.11 | 0.03 | 0.25 | 0.09 | family with sequence similarity 55, member C |
| 37 | C3orf19 | 0.63 | 0.37 | −0.04 | −0.32 | 0.20 | −0.06 | chromosome 3 open reading frame 19 |
| 38 | PHF17 | 0.63 | 0.40 | 0.12 | −0.21 | −0.01 | −0.28 | PHD finger protein 17 |
| 39 | STXBP4 | 0.63 | 0.49 | −0.11 | −0.21 | 0.18 | −0.14 | syntaxin binding protein 4 |
| 40 | TNPO1 | 0.63 | 0.49 | −0.02 | 0.07 | 0.21 | 0.06 | transportin 1 |
| 41 | ALPK2 | 0.63 | 0.58 | 0.24 | −0.03 | 0.22 | 0.22 | alpha-kinase 2 |
| 42 | LOC541471 | 0.62 | 0.47 | 0.08 | −0.19 | 0.00 | −0.14 | Hypothetical LOC541471 |
| 43 | FERMT2 | 0.62 | 0.41 | 0.32 | −0.11 | −0.09 | −0.13 | fermitin family homolog 2 |
| 44 | CSGALNACT2 | 0.61 | 0.37 | 0.07 | −0.04 | 0.16 | 0.17 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
| 45 | EPB41L5 | 0.61 | 0.44 | 0.24 | −0.32 | −0.26 | −0.08 | erythrocyte membrane protein band 4.1 like 5 |
| 46 | CRTAP | 0.61 | 0.54 | −0.14 | 0.09 | 0.39 | 0.20 | cartilage associated protein |
| 47 | BCHE | 0.61 | 0.59 | 0.28 | −0.22 | 0.03 | −0.17 | butyrylcholinesterase |
| 48 | CEP170 | 0.61 | 0.46 | −0.02 | −0.22 | −0.07 | −0.15 | centrosomal protein 170kDa |
| 49 | CHN1 | 0.61 | 0.37 | 0.10 | −0.12 | 0.02 | 0.12 | chimerin 1 |
| 50 | DDAH1 | 0.61 | 0.56 | −0.23 | 0.12 | 0.51 | 0.33 | dimethylarginine dimethylaminohydrolase 1 |
Significant R values are bolded and italicized. Genes of interest are highlighted in gray.